BERNADETTE SISNORIO: Open Payments
NPI 1073102653 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,476 in 105 payments from 21 companies in 2025. Trend: 2023 $2,434 · 2024 $2,295 · 2025 $2,476
Food & beverage: $2,476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $1,156 |
| PFIZER INC. | 16 | $243 |
| Lundbeck LLC | 12 | $221 |
| Amgen Inc. | 2 | $133 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| ARGENX US, INC. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| UCB, Inc. | 2 | $63 |
| Janssen Biotech, Inc. | 2 | $41 |
Products named: QULIPTA, BOTOX, UBRELVY, NURTEC ODT, VYEPTI, UPLIZNA, KESIMPTA, REXULTI.
Industry payments across NV — which companies pay providers there.
